Publications by authors named "Concha Rivas"

Claim this Profile
C
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.
Pau Montesinos, Chelo Rayón, Edo Vellenga, Salut Brunet, José González, Concha Rivas

Blood· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Martin S Tallman, Haesook T Kim, Pau Montesinos, Frederick R Appelbaum, Javier de la Serna, Concha Rivas

Blood· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy.
Pau Montesinos, José D González, José González, Chelo Rayón, Elena de Lisa, Concha Rivas

J Clin Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.
Miguel A Sanz, Pau Montesinos, Chelo Rayón, Alexandra Holowiecka, Javier de la Serna, Concha Rivas

Blood· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
José Cervera, Pau Montesinos, Jesús M Hernández-Rivas, María J Calasanz, Anna Aventín, Concha Rivas

Haematologica· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
Pau Montesinos, Joaquín Díaz-Mediavilla, Guillermo Debén, Virginia Prates, Mar Tormo, Concha Rivas

Haematologica· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Pau Montesinos, Juan M Bergua, Edo Vellenga, Chelo Rayón, Ricardo Parody, Concha Rivas

Blood· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.
Miguel A Sanz, Pau Montesinos, Edo Vellenga, Consuelo Rayón, Javier de la Serna, Concha Rivas

Blood· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
Javier de la Serna, Pau Montesinos, Edo Vellenga, Chelo Rayón, Ricardo Parody, Concha Rivas

Blood· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia.
Miguel A Sanz, Edo Vellenga, Chelo Rayón, Joaquín Díaz-Mediavilla, Concha Rivas

Blood· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.
Miguel A Sanz, Guillermo Martín, Marcos González, Angel León, Chelo Rayón, Concha Rivas

Blood· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis